Surgery Partners (NASDAQ:SGRY) Shares Up 5.7%

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) traded up 5.7% during mid-day trading on Monday . The stock traded as high as $26.45 and last traded at $25.92. 318,638 shares changed hands during trading, a decline of 64% from the average session volume of 880,022 shares. The stock had previously closed at $24.53.

Wall Street Analysts Forecast Growth

SGRY has been the topic of several recent research reports. Barclays initiated coverage on shares of Surgery Partners in a report on Wednesday, March 6th. They set an “equal weight” rating and a $35.00 target price on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Wednesday, April 10th. Benchmark restated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research report on Wednesday, May 1st. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a report on Thursday, February 29th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $43.63.

Surgery Partners Stock Up 4.4 %

The company has a market cap of $3.25 billion, a P/E ratio of -260.60, a PEG ratio of 2.24 and a beta of 2.75. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.71 and a quick ratio of 1.57. The business’s 50 day moving average price is $27.63 and its 200-day moving average price is $29.79.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Monday, February 26th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. The business had revenue of $735.40 million for the quarter, compared to the consensus estimate of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. During the same quarter in the prior year, the company earned $0.22 EPS. The firm’s quarterly revenue was up 4.0% on a year-over-year basis. On average, analysts anticipate that Surgery Partners, Inc. will post 0.78 earnings per share for the current fiscal year.

Insider Activity at Surgery Partners

In other news, insider Bradley R. Owens sold 1,040 shares of Surgery Partners stock in a transaction on Monday, February 12th. The stock was sold at an average price of $35.22, for a total value of $36,628.80. Following the completion of the sale, the insider now directly owns 73,149 shares of the company’s stock, valued at approximately $2,576,307.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Surgery Partners news, insider Bradley R. Owens sold 1,040 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $35.22, for a total transaction of $36,628.80. Following the completion of the sale, the insider now owns 73,149 shares in the company, valued at approximately $2,576,307.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jason Eric Evans sold 5,780 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $35.08, for a total value of $202,762.40. Following the completion of the transaction, the chief executive officer now owns 419,118 shares in the company, valued at $14,702,659.44. The disclosure for this sale can be found here. Insiders sold a total of 14,831 shares of company stock valued at $482,609 over the last quarter. Corporate insiders own 2.60% of the company’s stock.

Hedge Funds Weigh In On Surgery Partners

Hedge funds have recently modified their holdings of the stock. DekaBank Deutsche Girozentrale bought a new position in shares of Surgery Partners in the third quarter valued at $39,000. Strs Ohio bought a new position in shares of Surgery Partners in the 4th quarter valued at about $51,000. Signaturefd LLC acquired a new position in shares of Surgery Partners during the 3rd quarter worth about $56,000. Nisa Investment Advisors LLC raised its holdings in shares of Surgery Partners by 69.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company’s stock valued at $86,000 after purchasing an additional 1,210 shares during the period. Finally, Mesirow Institutional Investment Management Inc. lifted its stake in Surgery Partners by 12.4% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock valued at $108,000 after purchasing an additional 373 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.